Childhood Diabetes Supplies Insurance Denied for Your Child? How to Appeal

Type 1 diabetes (T1D) in a child requires constant, vigilant management — every day, every meal, every night. The supplies and technology that make safe T1D management possible — continuous glucose monitors (CGMs), insulin pumps, and closed-loop automated insulin delivery systems — are not conveniences. They are medically necessary tools that prevent hypoglycemia, reduce long-term complications, and protect your child's life. Insurance denials for these supplies are both common and frequently overturned on appeal.

Why Insurers Deny Childhood Diabetes Supplies

CGMs denied as "not meeting criteria." Insurers apply outdated coverage criteria — often requiring documented severe hypoglycemia episodes, insulin pump use, or specific A1C thresholds before approving a CGM. These criteria contradict the American Diabetes Association (ADA) Standards of Medical Care, which recommend CGMs for all people with T1D who are able to use them safely, regardless of A1C level or insulin delivery method. ICD-10 code E10.649 (Type 1 diabetes with hypoglycemia without coma) supports the medical necessity of hypoglycemia monitoring.

Insulin pumps denied. Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization for insulin pumps is commonly denied based on requirements to "fail" multiple daily injection (MDI) therapy first. ADA and the International Society for Pediatric and Adolescent Diabetes (ISPAD) do not require MDI failure as a prerequisite for pump therapy — insulin pumps are an appropriate first-line option for children with T1D.

Closed-loop systems denied as "experimental." FDA-approved automated insulin delivery (AID) systems including Tandem t:slim X2 with Control-IQ, Omnipod 5, and Medtronic MiniMed 780G are cleared medical devices, not experimental technology. Classifying them as investigational is factually incorrect and a strong basis for appeal.

Pump supplies denied or covered at a lower rate. Infusion sets, reservoirs, CGM sensors, and transmitters are frequently denied even when the device itself is approved, or covered at a lower durable medical equipment (DME) rate than the device authorization.

Insulin brand or type denied. Analog insulins (lispro, aspart, glargine, detemir, degludec) may be denied in favor of older formulations. Analog insulins are the ADA standard of care for T1D — substitution with older formulations is not clinically equivalent and carries higher hypoglycemia risk.

Diabetes education visits denied. Certified diabetes care and education specialist (CDCES) visits are a covered preventive service under many ACA plans and are essential for pediatric T1D management.

Your Legal Rights

ACA essential health benefits. Pediatric care, prescription drugs, and durable medical equipment (DME) are essential health benefits required in ACA-compliant plans. CGMs and insulin pumps are covered DME for pediatric T1D.

State CGM coverage mandates. A growing majority of states have enacted laws requiring health insurance coverage of CGMs for individuals with T1D. If your state has a CGM mandate and your plan is fully insured, a denial may be a direct violation of state law. Contact your state's insurance commissioner to confirm whether a mandate applies to your plan.

State insulin access laws. Many states cap out-of-pocket insulin costs and prohibit unreasonable access barriers to insulin. If your child's insulin is denied or subject to excessive cost-sharing, your state's insulin access statute may apply.

ACA prohibition on pre-existing condition exclusions. No insurer can deny coverage to your child because they have T1D.

ERISA protections. For employer-sponsored plans, ERISA guarantees the right to appeal, access the complete claims file, and receive a written denial explanation citing the specific criteria applied.

Step-by-Step Appeal Process

Step 1 — Identify the specific denial. Is it the device (CGM, pump, AID system), the supplies, the insulin, or the education visit? Each requires different documentation.

Step 2 — Request the insurer's clinical coverage criteria. Obtain the specific policy document used to deny the claim. Compare it against ADA Standards of Medical Care (published annually) and ISPAD guidelines.

Step 3 — Obtain your endocrinologist's letter of medical necessity. The letter should include: your child's T1D diagnosis (ICD-10: E10.649 for hypoglycemia risk; E10.65 for T1D with hyperglycemia), A1C history, hypoglycemia history, rationale for the specific device or supply, and citation to ADA and ISPAD guidelines supporting the requested technology.

Step 4 — For AID system "experimental" denials. Include the FDA 510(k) clearance number or PMA approval for the specific device. FDA approval directly refutes an "experimental" classification.

Step 5 — File the internal appeal within the deadline on your denial notice (typically 180 days for commercial plans). Send via certified mail and through the insurer's member portal.

Step 6 — Request peer-to-peer review. Your child's endocrinologist should speak directly with the insurer's medical reviewer.

Step 7 — Escalate. If the internal appeal is denied, request External Independent Review: Complete Guide" class="auto-link">external review and file a complaint with your state's department of insurance, citing any applicable state CGM or insulin access mandate.

Documentation Checklist

• Denial letter with reason code and appeal deadline
• Insurer's coverage criteria document for the denied device or supply
• Endocrinologist's letter of medical necessity (with ICD-10 codes E10.649 / E10.65)
• A1C history and hypoglycemia documentation
• ADA Standards of Medical Care citation supporting the technology
• FDA approval/clearance documentation (for AID system "experimental" denials)
• State CGM mandate citation (if applicable)
• State insulin access law citation (if applicable to insulin denials)

Fight Back With ClaimBack

Childhood T1D supply denials frequently rest on outdated clinical criteria that conflict with current ADA and ISPAD standards. A well-documented appeal that cites current guidelines and invokes state CGM mandates where applicable wins a high proportion of these denials. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal